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Introduction
“Asthma is the most common chronic 
disease in children. Asthma often begins 
in childhood, and it remains a worldwide 
serious public health problem reaching 
epidemic proportions” (Deng et al., 
2019, p. 1).
• According to the Global Asthma 
Report 2018, an estimated 340 
million persons are experiencing 
asthma, and nearly 1000 persons 
die of asthma-related conditions 
per day, and most of these deaths 
are preventable, highlighting the 
importance of early prevention 
measures in promoting pulmonary  
health, especially among children. 
(Deng et al., 2019, p. 1) 
• “Asthma is one of the most 
common causes of respiratory 
distress. It affects more than 6.2 
million children in the United 
States younger than 18 years of age 
and accounted for 20 million ED 
visits in 2014” (Agbim et al., 2018, 
p. 49). 
• “Respiratory failure is the most 
common cause of cardiopulmonary 
arrest in the pediatric population; 
therefore, it is important 
emergency providers to recognize 
respiratory distress quickly in 
children of all ages and intervene 
aggressively to prevent respiratory 
failure” (Agbim et al., 2018, p. 41). 
• “Asthma is a serious disease 
causing wheezing, difficulty 
breathing, and coughing. Over a 
lifetime, it can cause permanent 
lung damage. About 16% of black 
children and 7% of white children 
have asthma” (CDC, 2018). 
• “More than half of children with 
asthma had one or more attacks in 
2016. Every year, 1 in 6 children 
with asthma visits the Emergency 
Department with about 1 in 20 
children with asthma hospitalized 
with asthma” (CDC, 2018). 
Signs and Symptoms
Promote Healthy Choices
A study completed by Deng et al. 
(2019), identified that obesity having 
correlation with asthma in children 
related to obesity-reduction in lung 
volume (mechanical effects of obesity) 
and changes in hormone, dyslipidemia, 
and inflammatory mediators (p. 11). 
• “Sedentary behavior can lead to 
central adiposity and obesity, and 
excessive high-fat and low in 
antioxidant content diet is 
associated with an increased risk 
of asthma” (Deng et al., 2019, p. 
12). 
• “Childhood obesity is recognized 
as a new pandemic of the new 
millennium” (Poorolajal et al., 
2019, p. 116).
• “Eating breakfast and physical 
activity were the first and second 
most powerful protective factors 
against excess weight gain in 
children and adolescents” 
(Poorolajal et al., 2019, p. 116).
• “Watching too much TV and lack of 
enough sleep was the first and 
second most powerful risk factors 
of childhood obesity” (Poorolajal et 
al., 2019, p. 116).
Conclusion
Effective management of pediatric 
asthma and education are both vital 
components to improve the pediatric 
patient’s quality of life. Family centered 
care is pivotal to prevent asthma 
exacerbations and possible emergency 
department visits and admissions.
My goal is to provide a framework for 
the pediatric asthma patient and his or 
her caregivers to achieve autonomy 
with management of asthma, increasing 
quality of life.
• Oxygen saturation can be 
misleading in patients with 
asthma because of ventilation and 
perfusion (V/Q) mismatching. 
This may be apparent after the 
initial administration of a 
bronchodilator. For example, 
patients with asthma may 
experience a further decline in 
their oxygen saturation after 
receiving albuterol, due to V/Q 
mismatch or intrapulmonary 
shunting, even though their 
overall clinical status is 
improving. The decline in oxygen 
saturation should be temporary.
• Persistent decline in oxygenation 
and further respiratory distress 
would indicate deteriorating 
respiratory status. (Agbim et al., 
2018, p. 49)
• “Patients with persistent or 
refractory asthma symptoms 
require repeated doses of 
continuous albuterol, additional 
therapy, and prolonged 
observation in the Emergency 
Department or hospital” (Agbim
et al., 2018, p. 51). 
“Children experience chest tightness, 
dyspnea, wheezing, coughing, and 
anxiety during acute asthmatic episodes, 
inhibiting their ability to breathe and 
accomplish daily activities. These 
episodes can be frightening, life 
threatening, and detrimental to a child’s 
well-being” (Woodley, 2019, p. 191).
• Patients with asthma exacerbation 
will present with shortness of 
breath or chest tightness, an 
audible wheeze on auscultation, 
and possibly hypoxia (Agbim et al., 
2018, p. 49)
• Mild Distress: Involves tachypnea 
and shortness of breath. (Agbim et 
al., 2018, p. 42)
• Moderate Distress: Subcostal 
retractions and nasal flaring. 
(Agbim et al., 2018, p. 42)
• Severe Distress: Supraclavicular 
tugging and head bobbing. (Agbim
et al., 2018, p. 42)
“Some cases of severe respiratory 
distress, the entire sternum may retract, 
which is referred to paradoxical 
breathing” (Agbim et al., 2018, p. 42). 
Influenza Vaccine for the Pediatric 
Patient: 
• People with asthma are at risk of 
complications from flu. Flu 
infection in lungs can trigger 
asthma attacks, worsen asthma 
symptoms, and may lead to 
development of pneumonia. 
Centers for Disease Control and 
Prevention (CDC) recommends that 
people 6 months of age and older 
get a flu vaccine every year to 
protect against getting the flu and 
complications from flu. (CDC, 2017)
Identifying Triggers:
• Triggers can be very different from 
those of someone else with asthma. 
Know your triggers and learn how 
to avoid them. Watch out for an 
attack when you can’t avoid the 
triggers. Some of the most common 
triggers: 
• Tobacco Smoke, Dust Mites, 
Outdoor Air Pollution, Cockroach 
Allergan, Pets, Mold, Smoke from 
Burning Wood or Grass. 
• Other Triggers: Influenza, Colds, 
and Respiratory Syncytial Virus 
(RSV), Sinus Infections, Strong 
emotions can lead to 
hyperventilation that can also cause 
an asthma attack (CDC, 2020)
Missing any school because of asthma is 
associated with suboptimal asthma 
control; assessment of school 
absenteeism may serve as a health status 
indicator for the pediatric asthma patient 
(Hsu et al., 2016, p. 23).
• Asthma is a leading cause of chronic 
disease-related school absenteeism 
in the US., associated with more 
than 10 million missed school days 
annually. Asthma-related school 
absenteeism affects most (59%) 
children with asthma and is linked 
to lower academic performance, 
especially among urban minority 
youth. (Hsu et al., 2016, p. 23)




phenotype, irritants, pollutants, and 
viruses trigger an innate Th-1 cell-
mediated pathway that leads to 
subsequent neutrophil release. This 
asthma phenotype responds poorly 
to standard asthma therapy (Rali et 
al., 2020, p. 135).
• Eosinophilic-predominant 
phenotype, environmental allergic 
antigens induce a Th-2 cell-mediated 
response in the airways of patients 
with asthma. This creates a 
downstream effect on the release of 
interleukins (IL) including IL-4, IL-5, 
and IL-13. IL-4 triggers 
immunoglobulin (Ig) E release, 
which induces mast cells to release 
inflammatory cytokines, while IL-5 
and IL-13 are responsible for 
eosinophilic response. These 
cytokines and eosinophils induce 
airway hyperresponsiveness, 
remodeling, and mucus production. 
Through repeated exposure, chronic 
inflammation develops and 
subsequently causes structural 
changes related to increased smooth 
muscle mass, goblet cell hyperplasia, 
and thickening of lamina reticularis. 
(Rali et al., 2020, p. 135-136)
Pathophysiological Processes
Airway Obstruction:
• Early asthmatic response is due to 
acute bronchoconstriction secondary 
to IgE; this is followed by airway 
edema occurring 6 to 24 hours after 
an acute event (called late asthmatic 
response). The obstruction is 
worsened by an overproduction of 
mucus, which may take weeks to 
resolve. Longstanding inflammation 
can lead to structural changes and 
reduced airflow reversibility. (Rali et 
al., 2020, p. 136)
Bronchial hyperresponsiveness:
• Is induced by various forms of 
allergens, pollutants, or viral upper 
respiratory infections. Sympathetic 
control in the airway is mediated via 
beta-adrenoceptors expressed on 
airway smooth muscle, which is 
responsible for the effect of 
bronchodilation in response to 
albuterol. Cholinergic pathways may 
further contribute to bronchial 
hyperresponsiveness and form the 
basis for the efficacy of anticholinergic 
therapy. (Rali et al., 2020, p. 136)
Asthma is mediated through either type 1 T-helper (TH-1) cell or a type 2 T-helper 
(Th-2) cell response, the pathways of which have a fair amount of overlap (Rali et al., 
2020, p. 135).
Figure 2    
Improving management of pediatric 
asthma through education: 
• The pediatric patient and caregivers 
can improve asthma management 
with education and instruction of 
inhaler technique. “The National 
Heart, Lung, and Blood Institute 
guidelines recommend that 
providers check inhaler technique 
at every opportunity and correct 
any deficiencies seen” (Gillette et al., 
2016, p. 613).
• Pediatric education is continuously 
developing along with the pediatric 
patient to support pediatric patient 
autonomy of asthma management.
• The most common steps performed 
incorrectly were inhaling slowly 
and deeply for 3 to 4 seconds, 
holding breath for 5 to 10 seconds, 
and waiting 30 seconds before 
repeating if a second dose was 
necessary and not shaking the 
metered dose inhaler (MDI) prior to 
use with the spacer. (Gillette et al., 
2016, p. 607)
Following the Asthma Action Plan:
• How to identify allergens or 
irritants to avoid
• How to recognize and handle 
asthma attacks
• Which medications to take and 
when to take them
• When to call your doctor or go to 
the emergency room
• Who to contact in an emergency
(U.S. Department of Health and Human 
Services, 2020)
• Assessing if the asthma action plan 
is effective for the patient and that 
the plan is being utilized correctly.
